Advanced Electrophoretic Mobility Shift Assay (EMSA) Service

Q: What is the difference between EMSA and ChIP-Seq?

EMSA is an in vitro method that confirms a direct interaction between a specific protein and a specific nucleic acid sequence in a controlled environment. ChIP-Seq is an in vivo method that identifies all the genomic regions a protein is bound to within a cell at a specific moment. EMSA is excellent for validating ChIP-Seq hits.

Background Service Portfolio Workflow Application Advantage Related Services FAQ Online Inquiry

In the intricate world of molecular biology, the interactions between proteins and nucleic acids govern the very essence of cellular function—from gene expression and replication to DNA repair and signaling pathways. The Electrophoretic Mobility Shift Assay (EMSA), also known as a gel shift or gel retardation assay, stands as a cornerstone technique for this discovery. For over two decades, Creative Biolabs has been at the forefront, providing robust, sensitive, and highly reliable EMSA services to researchers worldwide, empowering them to decode these critical molecular dialogues. Our platform is not just about running gels; it's about providing insightful, publication-quality data that propels your research forward.

Discuss Your Project Today

What is Electrophoretic Mobility Shift Assay (EMSA)?

The Electrophoretic Mobility Shift Assay (EMSA), also known as a gel shift assay, is a common and powerful laboratory technique used to study the interactions between proteins and nucleic acids (DNA or RNA). It is a fundamental tool in molecular biology for identifying proteins that bind to specific sequences of DNA or RNA and for characterizing the properties of these interactions.

The Basic Principle of EMSA

The core idea behind EMSA is based on the difference in the rate of migration of nucleic acid molecules through a gel matrix when they are free versus when they are bound to a protein.

Free Nucleic Acid: A labeled fragment of DNA or RNA will migrate through a non-denaturing gel at a certain speed, determined by its size and charge.
Protein-Nucleic Acid Complex: When a protein binds to this nucleic acid fragment, it forms a larger, bulkier complex. This complex will move more slowly through the gel matrix compared to the unbound nucleic acid.
The "Shift": This difference in migration speed results in a "shift" in the position of the band on the gel. The band corresponding to the protein-bound nucleic acid will be higher up on thegel (meaning it has traveled a shorter distance) than the band for the free nucleic acid.

Fig. 1 Electrophoretic mobility shift assays (EMSA). (OA Literature). Fig. 1 The schematic illustration of electrophoretic mobility shift assays (EMSA).1

Our Comprehensive EMSA Service Portfolio

Creative Biolabs offers a suite of EMSA services tailored to meet diverse research objectives.

Standard EMSA (Binding Confirmation)

The foundational service to quickly and reliably determine if your protein of interest binds to a specific DNA or RNA sequence.

Competitive EMSA (Specificity Assay)

To prove the binding is specific, we introduce unlabeled competitor probes. A specific interaction will be outcompeted by a specific unlabeled probe but not by a non-specific or mutated probe.

Supershift EMSA (Protein Identification)

This powerful variation involves adding an antibody specific to the protein of interest into the binding reaction. If the protein is part of the complex, the antibody will bind to it, creating an even larger "supershifted" complex, thus confirming the protein's identity.

Quantitative EMSA (Affinity Determination)

By titrating the protein concentration while keeping the probe concentration constant, we can accurately calculate the dissociation constant (Kd), a critical measure of binding affinity.

A Streamlined Workflow of EMSA for Actionable Results

We have developed a transparent and efficient project workflow to ensure a seamless experience and timely delivery of high-quality data.

Initial Consultation: We discuss your project goals, experimental design, and required materials.
Probe & Protein Preparation: Includes probe design, synthesis, and high-purity labeling (fluorescent, biotin, etc.). We can also assist with your target protein expression and purification if needed.
Binding Condition Optimization: Our experts meticulously optimize buffer composition, incubation times, and temperature to ensure robust and specific complex formation.
Electrophoresis & Transfer: High-resolution gel electrophoresis followed by efficient transfer to a membrane for detection.
Signal Detection & Imaging: Utilization of advanced imaging systems for sensitive signal detection.
Data Analysis & Reporting: Comprehensive analysis, including image quantification, Kd calculation (if applicable), and a detailed report with all methods, raw data, and expert interpretation.

Applications: Powering Discovery Across Disciplines

Our EMSA services provide critical insights for a wide range of research areas:

Gene Regulation: Characterizing transcription factor binding to promoter and enhancer regions.
DNA Repair Mechanisms: Studying how repair proteins recognize and bind to damaged DNA sites.
Pharmacology & Drug Discovery: Screening small molecules that inhibit or enhance protein-nucleic acid interactions.
Virology: Investigating the binding of viral proteins to host DNA or RNA.
RNA Biology: Analyzing the function of RNA-binding proteins (RBPs) in post-transcriptional regulation.
Recombinase & Integrase Activity: Assessing the binding activity of enzymes involved in DNA recombination.

Why Choose Creative Biolabs for Your EMSA Services?

Navigating the nuances of EMSA requires deep technical expertise. From probe design to optimizing binding conditions, many factors can influence the outcome. Partnering with Creative Biolabs eliminates these hurdles and provides you with a distinct advantage.

Unmatched Sensitivity with Modern Platforms: We have largely moved beyond radioactive probes to safer, more stable, and highly sensitive non-radioactive detection systems, including fluorescence (e.g., Cy3, Cy5) and chemiluminescence (e.g., biotin-streptavidin). This ensures sharper bands, lower background, and easier quantification.
Quantitative Insights: We don't just show you a shift; we quantify it. Our services can include densitometric analysis to determine binding affinity (dissociation constant, Kd), providing crucial data on the strength of the interaction.
Deep Expertise & Troubleshooting: With 20+ years of experience, our scientists have optimized protocols for a vast range of proteins and nucleic acid sequences, including challenging low-affinity interactions and complex multi-protein systems. We anticipate problems before they arise.
Full-Spectrum Customization: Your project is unique. We offer end-to-end customization, from probe design and synthesis to protein expression and purification. We work with you to design an assay that precisely answers your research question.
High-Throughput Capability: For large-scale screening projects, such as identifying transcription factor inhibitors or screening mutant proteins, we offer streamlined high-throughput EMSA services to accelerate your discovery pipeline.

Complementary & Related Services

EMSA is often one piece of a larger puzzle. To provide a more complete picture of your biological system, consider our other relevant services:

Ready to move your research forward with definitive data? The experts at Creative Biolabs are here to help. Contact us today to discuss your project, and we will provide a detailed, customized proposal tailored to your specific needs.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQ)

Q: What is the difference between EMSA and ChIP-Seq?

A: EMSA is an in vitro method that confirms a direct interaction between a specific protein and a specific nucleic acid sequence in a controlled environment. ChIP-Seq is an in vivo method that identifies all the genomic regions a protein is bound to within a cell at a specific moment. EMSA is excellent for validating ChIP-Seq hits.

Q: What types of samples do you accept?

A: We can work with purified proteins, cell nuclear extracts, or custom-expressed proteins. For nucleic acids, we can work with your sequences or design and synthesize them for you.

Q: Can you help if I don't have purified protein?

A: Yes. Creative Biolabs offers premier Protein Expression and Purification Services. We can seamlessly integrate protein production into your EMSA project workflow.

Q: How much protein and nucleic acid is required?

A: This is highly dependent on the binding affinity. We typically recommend starting with at least 50-100 µg of purified protein and several micrograms of DNA/RNA, but our scientists will provide specific guidance during the consultation phase.

Reference

Song, Chengcheng, Shaocun Zhang, and He Huang. "Choosing a suitable method for the identification of replication origins in microbial genomes." Frontiers in microbiology 6 (2015): 1049. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fmicb.2015.01049

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.